Quotes 5-day view Delayed Nasdaq
06/27/2022
06/28/2022
06/29/2022
06/30/2022
07/01/2022
Date
0.9573(c)
0.9109(c)
0.9592(c)
0.9627(c)
0.91(c)
Last
500 802
387 303
334 134
201 194
221 376
Volume
+7.39%
-4.85%
+5.30%
+0.36%
-5.47%
Change
Estimated financial data (e) (USD)
Sales 2022
19,8 M
-
-
Net income 2022
-108 M
-
-
Net cash position 2022
30,2 M
-
-
P/E ratio 2022
-0,56x
Yield 2022
-
Sales 2023
16,7 M
-
-
Net income 2023
-135 M
-
-
Net Debt 2023
-
-
-
P/E ratio 2023
-0,46x
Yield 2023
-
Capitalization
57,2 M
57,2 M
-
EV / Sales 2022
1,36x
Capi. / Sales 2023
3,43x
Nbr of Employees
124
Free-Float
95,0%
Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on redefending the power of small molecules to control the expression of genes. The Company is engaged in developing treatments for cancer and diseases resulting from mutations of a single gene, also known as monogenic diseases, and building a clinical-stage pipeline of gene control medicine. The Company's lead product candidates...
Ratings of Syros Pharmaceuticals, Inc.
All news about SYROS PHARMACEUTICALS, INC.
07/01 Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BU
06/24 SYROS PHARMACEUTICALS, INC.(NASDAQGS : SYRS) dropped from Russell 2500 IndexCI
06/24 SYROS PHARMACEUTICALS, INC.(NASDAQGS : SYRS) dropped from Russell 2000 Dynamic IndexCI
06/24 SYROS PHARMACEUTICALS, INC.(NASDAQGS : SYRS) dropped from Russell 2000 Value IndexCI
06/24 SYROS PHARMACEUTICALS, INC.(NASDAQGS : SYRS) dropped from Russell Small Cap Comp Value Ind..CI
06/24 SYROS PHARMACEUTICALS, INC.(NASDAQGS : SYRS) dropped from Russell 2500 Value IndexCI
06/24 SYROS PHARMACEUTICALS, INC.(NASDAQGS : SYRS) dropped from Russell 3000E Value IndexCI
06/24 SYROS PHARMACEUTICALS, INC.(NASDAQGS : SYRS) dropped from Russell 2000 IndexCI
06/24 SYROS PHARMACEUTICALS, INC.(NASDAQGS : SYRS) dropped from Russell 2000 Growth IndexCI
06/24 SYROS PHARMACEUTICALS, INC.(NASDAQGS : SYRS) dropped from Russell Small Cap Comp Growth In..CI
06/24 SYROS PHARMACEUTICALS, INC.(NASDAQGS : SYRS) dropped from Russell 3000 Growth IndexCI
06/24 SYROS PHARMACEUTICALS, INC.(NASDAQGS : SYRS) dropped from Russell 3000E IndexCI
06/24 SYROS PHARMACEUTICALS, INC.(NASDAQGS : SYRS) dropped from Russell 3000E Growth IndexCI
06/24 SYROS PHARMACEUTICALS, INC.(NASDAQGS : SYRS) dropped from Russell 3000 Value IndexCI
06/24 SYROS PHARMACEUTICALS, INC.(NASDAQGS : SYRS) dropped from Russell 3000 IndexCI
News in other languages on SYROS PHARMACEUTICALS, INC.
Analyst Recommendations on SYROS PHARMACEUTICALS, INC.
Chart SYROS PHARMACEUTICALS, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends SYROS PHARMACEUTICALS, INC.
Short Term Mid-Term Long Term Trends Neutral Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
6
Last Close Price
0,91 $
Average target price
13,00 $
Spread / Average Target
1 329%
Please enable JavaScript in your browser's settings to use dynamic charts.